CoChat

A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin‐18 for the diagnosis of non‐alcoholic steatohepatitis in morbidly obese patients

Open access
Anty, R., Iannelli, A., Patouraux, S., Bonnafous, S., Lavallard, V. J., Senni‐Buratti, M., Ben Amor, I., Staccini‐Myx, A., Saint‐Paul, M.‐C., Berthier, F., Huet, P.‐M., Le Marchand‐Brustel, Y., Gugenheim, J., Gual, P., Tran, A. · 2010 · Alimentary Pharmacology & Therapeutics
Cited by 153

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Aliment Pharmacol Ther 2010; 32: 1315–1322 Summary: Background Non‐invasive approaches are useful to differentiate simple steatosis from non‐alcoholic steatohepatitis (NASH) in obese and morbidly obese patients. Aim To develop a new scoring system to diagnose definitive NASH. Methods Preoperative clinical and biological data including serum caspase 3‐generated cytokeratin‐18 fragments (CK18) and surgical liver biopsies were obtained from 464 morbidly obese patients who had undergone bariatric surgery. The cohort was divided into two groups: training group (n = 310) and validation group (n = 154). Definitive NASH was defined according to Kleiner’s classification with a Non‐alcoholic fatty liver disease Activity Score (NAS) ≥5. Results Alanine aminotransferase (ALT), CK18 fragments and the presence of metabolic syndrome were independent predictors for discriminating patients with NAS ≥5 in the training group. These three parameters were used to carry out a scoring system for the prediction of NAS ≥5. Whereas serum CK18 fragment alone had an area under the receiver operating characteristic (AUROC) curve = 0.74, AUROC curves of the scoring system were 0.88 and 0.83 in the training group and the validation group, respectively. Conclusion A simple and non‐invasive composite model (the Nice Model) including metabolic syndrome, ALT and CK18 fragments is able to predict accurately a non‐alcoholic fatty liver disease activity score ≥5 in morbidly obese subjects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2010.04480.x

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 153

Metadata

Authors
Anty, R., Iannelli, A., Patouraux, S., Bonnafous, S., Lavallard, V. J., Senni‐Buratti, M., Ben Amor, I., Staccini‐Myx, A., Saint‐Paul, M. ‐., Berthier, F., Huet, P. ‐., Le Marchand‐Brustel, Y., Gugenheim, J., Gual, P., & Tran, A.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2010-10-07
Volume
32
Issue
11-12
Pages
1315-1322
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W1509174047
Cited by
153
References
8
FWCI
5.66
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin‐18 for the diagnosis of non‐alcoholic steatohepatitis in morbidly obese patients. https://app.cochat.ai/papers/10.1111/j.1365-2036.2010.04480.x
The paper
Anty, R., Iannelli, A., Patouraux, S., Bonnafous, S., Lavallard, V. J., Senni‐Buratti, M., Ben Amor, I., Staccini‐Myx, A., Saint‐Paul, M. ‐., Berthier, F., Huet, P. ‐., Le Marchand‐Brustel, Y., Gugenheim, J., Gual, P., & Tran, A. (2010). A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin‐18 for the diagnosis of non‐alcoholic steatohepatitis in morbidly obese patients. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2010.04480.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.